Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix  by Wu, Chuanyue et al.
Cell, Vol. 83, 715-724, December 1, 1995, Copyright 0 1995 by Cell Press 
lntegrin Activation and Cytoskeletal Interaction 
Are Essential for the Assembly 
of a Fibronectin Matrix 
Chuanyue Wu,* Virginia M. Keivens,t 
Timothy E. OToole,t John A. McDonald,* 
and Mark H. Ginsberg+ 
*Department of Biochemistry and Molecular Biology 
Mayo Clinic Scottsdale 
13400 East Shea Boulevard 
Scottsdale, Arizona 85259 
TDepartment of Vascular Biology 
Scripps Research Institute 
10666 North Torrey Pines 
La Jolla, California 92037 
Summary 
Fibronectin (Fn) matrices are vital to vertebrate devel- 
opment and wound healing and modulate tumorigene- 
sis. We used a recombinant Fn-binding integrin, all&, 
to define rules for integrin-initiated Fn matrix forma- 
tion. We report the following. First, multiple Fn- 
binding integrins can support matrix assembly; their 
activation state controls fibrillogenesis. Second, Fn 
binding to cells expressing an activated integrin is nec- 
essary but not sufficient for matrix assembly. Addi- 
tional “postoccupancy”events involving the integrin p, 
but not the a subunit, cytoplasmic domain are needed. 
Third, these postoccupancy events require an intact 
actin cytoskeleton. We propose a model for integrin 
involvement in Fn fibrillogenesis that reconciles previ- 
ous paradoxes and suggests novel approaches to the 
therapeutic control of Fn matrix assembly. 
Introduction 
Fibronectin (Fn) is a glycoprotein indispensable for verte- 
brate embryogenesis (George et al., 1993). Fn exists both 
in a soluble form (plasma concentration - 1 PM) and as an 
insoluble matrix. Fn matrices are deposited in a temporally 
and spatially defined pattern utilizing both newly synthe- 
sized cellular Fn and soluble Fn (Mosher et al., 1992). 
Cells use these Fn matrices as migratory tracks during 
development (Boucaut et al., 1990). More importantly, the 
Fn matrix is imprinted with positional information that con- 
tributes to the directional migration of mesoderm (Boucaut 
et al., 1990; Winklbauer and Nagel, 1991). This positional 
information may be important for preservation of the left- 
right asymmetry (Yost, 1992) of the embryo. Cell migration 
along Fn matrices is also involved in wound healing (Clark 
and Colvin, 1985). Furthermore, loss of capacity to form 
an Fn matrix is a feature of the transformed phenotype 
(Hynes et al., 1978); restoration of matrix assembly corre- 
lates with reduced malignant behavior (Giancotti and Ru- 
oslahti, 1990). Thus, the generation of Fn matrices is vital 
in vertebrate development and response to injury, and its 
disruption may contribute to tumorigenesis. 
Fn matrix assembly often depends on Fn binding to 
integrins, ubiquitous heterodimeric adhesion receptors 
(Hynes, 1992). Fn fragments containing the a&-binding 
domain or antibodies against that domain (McDonald et 
al., 1987) or against a& itself (Fogerty et al., 1990; Aki- 
yama et al., 1989) block Fn matrix assembly in vitro. Chi- 
nese hamster ovary (CHO) cells lacking asPI assemble a 
matrix only after reconstitution of the integrin by transfec- 
tion (Wu et al., 1993). To date, the only integrin implicated 
in Fn fibrillogenesis is a&. Nevertheless, in the absence 
of a&, certain mesodermal structures form and cells can 
assemble a matrix (Yang et al., 1993), suggesting that 
other integrin or nonintegrin receptors can substitute for 
ad%. 
The role of integrins in matrix assembly is not com- 
pletely understood. Fn binds to layers of substrate-at- 
tached, matrix-forming cells in part via the N-terminal 70 
kDa domain of Fn (70K) (McKeown-Longo and Mosher, 
1983, 1985). The 70K fragment blocks matrix assembly 
(McDonald et al., 1987; Quade and McDonald, 1988), but 
is not known to interact directly with a&. Fragments of Fn 
that lack known integrin-binding sites can be incorporated 
into an existing Fn matrix (Schwarzbauer, 1991; Sottile 
and Wiley, 1994). Similarly, the first type Ill repeat in Fn 
(Ill-l) does not interact with a&, but seems to play a role 
in this process (Morla and Ruoslahti, 1992; Mosher et al., 
1992; Chernousov et al., 1991; Hocking et al., 1994; 
Aguirre et al., 1994). Furthermore, the expression of inte- 
grin a& is not sufficient to enable a cell to assemble an 
Fn matrix. For example, certain tumor cells show no reduc- 
tion in expression of this integrin (Akiyama et al., 1990; 
Dedhar and Saulnier, 1990). One explanation for these 
apparent paradoxes is that there might exist a distinct cell 
surface matrix assembly receptor that binds to the 70K 
N-terminal region of Fn (McKeown-Longo and Mosher, 
1985). 
The ligand binding affinity of many integrins is regulated 
by cellular signaling events. In particular, a& can exist 
in high (operationally defined as activated) or low affinity 
states with respect to Fn binding (Faull et al., 1993). A 
number of cell lines express only low affinity a& (Faull 
et al., 1993). These cells do not assemble an Fn matrix 
in vitro (R. Faull and M. H. G., unpublished data). Further- 
more, in the presence of physiological concentrations of 
soluble Fn, high affinity a$, is saturated with ligand and 
thus cannot mediate cell adhesion (Faull et al., 1993). Fi- 
nally, overexpression of isolated integrin fl cytoplasmic 
domains disrupts the high affinity state of integrins (Chen 
et al., 1994) and blocks matrix assembly (LaFlamme et 
al., 1994). Thus, the activation state of Fn-binding inte- 
grins, such as a&, may regulate fibrillogenesis. 
all&z (platelet GPllb-llla) is the most abundant platelet 
integrin and is a prototype for analysis of changes in inte- 
grin affinity. aI& becomes activated when platelets 
spread (Loftus and Albrecht, 1984) and form Fn fibrils 
(Hynes et al., 1978). Because all& is an Fn-binding inte- 
grin (Ginsberg et al., 1983; Gardner and Hynes, 1985; 
Parise and Phillips, 1986), it could enable platelets to as- 
semble an Fn matrix. Activation state can be precisely 
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controlled in recombinant all& by three distinct mecha- 
nisms. First, chimeras composed of the cytoplasmic do- 
mains of various a and f3 subunits joined to the transmem- 
brane and extracellular domains of alI& can be activated 
via energy-dependent, cell type-specific cellular machin- 
ery (O’Toole et al., 1994). Second, elimination of the con- 
served membrane-proximal GFFKR motif in the a subunit 
cytoplasmic domain (Figure 1) activates aII&. These dele- 
tion mutantsdo not utilize thecellular machinery employed 
by the chimeras; hence, they have been termed hinge 
mutants to emphasize this distinction (07oole et al., 
1994). Third, certain monoclonal antibodies, e.g., anti- 
LlSS6 (Frelinger et al., 1991), bind directly to aI& and 
activate it independent of cellular context. To test the hy- 
pothesis that the activation state of Fn-binding integrins 
regulates fibrillogenesis, we examined the capacity of re- 
combinant ajIbS to assemble an Fn matrix in CHO cells. 
Our results demonstrate that two distinct features of a 
Fn-binding integrin are essential elements in assembly of 
a Fn matrix. These are activation of the integrin to bind 
Fn with high affinity and postreceptor occupancy events 
that require an intact b subunit cytoplasmic domain. To- 
gether, these results define a testable model of the essen- 
tial and initial steps in Fn matrix assembly and document 
the importance of its control via modulation of the func- 
tional state of integrins. 
“5 -- Pt - 
aLA(b”GFFK)------- 
Figure 1. Schematic Representation of a& lntegrin Constructs Ex- 
pressed in CHO Cells 
The alI& constructs expressed in CHO cells are depicted above, and 
the cytoplasmic components used to create these mutant a& inte- 
grins are displayed in the box below. The GFFKR sequence of the a 
cytoplasmic domain is depicted with a stippled rectangle. Deletion of 
this sequence activates a&. Furthermore, joining the cytoplasmic 
domain of u5 to the extracellular and transmembrane domain of allb 
also activates a,,&. All up combinations that impart increased ligand 
binding affinity are indicated by asterisks (Loftus et al., 1990; O’Toole 
et al., 1989, 1990, 1994). 
Anti-a,,,& Anti-a5 + Anti-alrb& 
Chimera 
(100) 
Figure 2. Control of Matrix Assembly by Inte- 
grin Cytoplasmic Domains 
(A-F) CHO Kl cells expressing wild-type ailbPs 
integrin (A-C) or the '~~,~a&&, chimera (D-F) 
were cultured in a-MEM medium containing 
10% Fn-depleted FBS and 600 nM bovine 
plasma Fn for 2 days in the presence of mono- 
clonal antibody PBl to a$, (A, C, D, and F), 
or antibody 2G12 to ai& (Et, C, E, and F). Fn 
was detected by indirect immunofluorescence 
as described in the Experimental Procedures. 
The scale bar in (A) is 50 pm and applies to all 
panels. Note the abundant Fn matrix deposited 
by cells expressing the •Q~,~Q&!~~ chimera(D), 
which is deposited in the presence of the a& 
inhibiting antibody. Antibodies to both a&, and 
QII& block Fn matrix assembly. 
(G) The levels of surface expression of a& 
and a5 integrins in CHO Kl cells expressing 
wild-type al& integrin (allbp3), CHO Ki cells 
expressing the *allba&~, chimera, and CHO 
Kl cells (CHO). The cells were stained with the 
anti-a,& antibody D57, or the anti-a& anti- 
body PBl, and an FITC-conjugated goat anti- 
mouse secondary antibody, and then analyzed 
by flow cytometry as described in the Experi- 
mental Procedures. The numbers in parenthe- 
ses represent the geometric mean fluores- 
cence intensities. 
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Results 
lntegrin Cytoplasmic Domains Control 
Fn Matrix Assembly 
The cytoplasmic domains of integrins regulate their func- 
tional state. To assess the capacity of these domains to 
control assembly of the Fn matrix, we used CHO cells 
expressing recombinant al&, an Fn-binding integrin 
whose functional state is readily assessed. Because these 
cells can utilize endogenous a& to form an Fn matrix, 
we added saturating quantities of an anti-as antibody, PBl 
(Brown and Juliano, 1985, 1988). Under these conditions, 
the a&,-expressing CHO cells did not form Fn fibrils (Fig- 
ure 2A). The same cells assembled an Fn matrix in the 
presence or absence of the allb6S-blQCking antibody 2G12 
(Figure 2B), indicating that the cells could form Fn fibrils‘ 
using endogenous hamster a&. Thus;.‘wild-type all&. 
failed to support.Fn matrix assembly’;Nhen expressed in.,, 
CHO Ki cells. _’ 
%baLAP3’B2* 
+ Anti-a,& 
To determine whether integrin cytoplasmic’domaihs’ ( 1 
regulate matrix assembly, we joined this portion of ‘ci& 
‘to theextracellular and transmembrane domains of allbP3 
to form the *aII&8& chimera (see Figure 1). CHO cells ^’ 
that expressed this chimera assembled an Fn matrix in 
the presence of an a&-blocking antibody (Figure 2D). 
Moreover, a combination of both aII&- and a&-blocking 
antibodies was required to ablate Fn matrix assembly by 
these cells (Figure 2F); either antibody alone failed to do 
so. The ability of the chimeric *allba&j& integrin to support 
matrix assembly was not attributable to enhanced biosyn- 
thesis of endogenous a&, as expression levels were simi- 
lar to those in the a,,&-transfected cells (Figure 2G). Thus, 
replacing the cytoplasmic domains of all& integrin with 
those of a& integrin enabled alI& to support Fn matrix 
assembly. 
Fn Matrix Assembly Depends on lntegrin Activation 
The *allba&(jl chimera differs from alI& in its ligand bind- 
ingaffinityinCHOcells(07ooleetal., 1994).Todetermine 
whether activation is vital for initiation of Fn matrix assem- 
bly, we employed a mutation that enhances ligand binding 
affinity through a mechanism different from that of the 
*allba&& chimera. The *allbaLA chimera (see Figure 1) 
was expressed with 83 in as-deficient CHO 82 cells. In 
the *allbaLA chimera, the conserved VGFFK sequence is 
deleted (see Figure 1). When l allbaLA is expressed with 
f&, the resulting integrin exhibits high affinity ligand bind- 
ing that is independent of cellular signaling machinery 
(07oole et al., 1994). Consistent with their deficiency of 
endogenous a& (Schreiner et al., 1989; Wu et al., 1993), 
CHO 82 cells expressing wild-type a,,& integrin did not 
assemble an Fn matrix (Figure 3A). In contrast, CHO 82 
cells expressing similar levels (Figure 3E) of *allbaLAps did 
so (Figure 3B). Matrix assembly by these cells depended 
on the al& extracellular domain, since it was inhibited 
by the all&-blOCkirIg antibody 2G12 (Figure 3C) or the 
all&specific inhibitor R044-9883 (data not shown). Iden- 
tical results were obtained when CHO Kl cells expressing 
the same *C&C&& chimera were tested in the presence 
of the a&blocking antibody PBl (data not shown). Thus, 
“Irb%P3’B2* 
+ Control Ab 
Figure 3. Deletion of the VGFFK Sequence from the allb Cytoplasmic 
Domain Activates Fn Matrix Assembly 
as-deficient CHO 82 cells expressing the *uIIbaLA chimera f& inte- 
grin (B-D) or control cells expressing wild-type CX,,J~~ integrin (A) were 
cultured in medium supplemented with 480 nM bovine plasma Fn 
alone (A and B), or containing Fn and 2.1 PM anti-a,,& inhibitory 
antibody 2G12 (C), or 2.1 uM anti-a,,& noninhibiting control antibody 
Ab15 (D). An abundant matrix deposited by CHO 82 cells expressing 
the activated *u,,~u~A chimeric 83 integrin (B) was blocked by the 2G12 
monoclonal antibody inhibiting a,,& integrin but not by the control 
anti-a,,& antibody Ab15. Scale bar in (A) is 50 pm and applies to all 
panels. 
(E) The levels of surface expression of a,,&, and cc6 integrins in CHO 
82 cells expressing wild-type a,& integrin (a&, CHO 82 cells ex- 
pressing the ‘aIlbuLA chimera (aLA), and CHO 82 cells (82). The cells 
were stained with the anti-a& antibody D57 or the anti-a&, antibody 
PBI and an FIT&conjugated goat anti-mouse secondary antibody, 
and then analyzed by flow cytometry as described in the Experimental 
Procedures. The numbers in parentheses represent the geometric 
mean fluorescence intensities. 
activation of alI& via a hinge mutation enables allb& to 
support Fn matrix assembly. 
The aI& integrin can be activated and maintained in 
a high affinity binding state by certain antibodies, such as 
anti-LIBSG(Frelingeretal., 1991). Weutilizedthisantibody 
as a third approach to examine the relationship between 
high affinity state and Fn matrix assembly. CHO cells ex- 
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also participate in matrix assembly by cells expressing 
activated a&, we utilized an antibody against the cell- 
binding domain of Fn (N294) and the 70 kDa N-terminal 
fragment of Fn (McDonald et al., 1987). Both reagents 
blocked Fn matrix formation (Figures 5A and 5C) by alI$J. 
transfected CHO B2 cells cultured in the presence of anti- 
LIBSG antibody. The inhibition was specific, as neither an 
irrelevant mouse immunoglobulin G (IgG) (Figure 58) nor 
a 60 kDa gelatin-binding Fn fragment that lacks the N-ter- 
minus had any effect (Figure 5D). The N294 antibody and 
the 70 kDa fragment also inhibited Fn matrix assembly 
mediated by the constitutively active l allbaLAp3 chimeric 
integrin (data not shown). Thus, both the cell-binding and 
N-terminal domains of Fn are involved in matrix assembly 
mediated by activated alI& and a&, consistent with a 
common mechanism supported by both integrins. 
The Fn matrix deposited by cells expressing a& is typi- 
cally stabilized by disulfide bonds (Keski-Oja, 1976; Ali 
and Hynes, 1978) and resists solubilization in sodium 
deoxycholate (McKeown-Longo and Mosher, 1983). To 
determine whether the Fn matrix assembled by cells ex- 
pressing activated alI& integrin shares these characteris- 
tics, we cultured CHO Kl cells expressing the constitu- 
tively active *allbaLAp3 chimera, as well as control CHO 
A5 cells expressing inactive wild-type aI& integrin, with 
‘z51-labeled Fn. The anti-a& antibody PBl was included 
in the culture media to block endogenous a& activity. 
After 48 hr, the cell layer was extracted with 2% deoxycho- 
late, and the deoxycholate insoluble matrix fraction was 
dissolved in SDS and analyzed by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) under nonreducing and 
reducing conditions. The l allbaLAP3 chimera (Figure 5E, 
lane a), but not the wild-type alI& integrin (lane b), caused 
formation of high molecular weight detergent-insoluble 
complexes containing 1Z51-labeled Fn. The formation of 
these complexes was inhibited by the a&-specific inhibi- 
tor R044-9883 (Figure 5E, lane c), confirming that alI& 
integrin participated in the assembly process. Disulfide 
bonds stabilized the multimeric Fn complexes, as mono- 
meric Fn subunits were released from the complex in the 
presence of dithiothreitol (Figure 5E, lane e). Some of the 
complexes resisted reduction. The nature of the bond(s) 
cross-linking Fn in these complexes is unknown, but could 
be &-(y-glutamyl)lysyl bond(s) catalyzed by transglutami- 
nase (Barry and Mosher, 1989). Thus, based on morphol- 
ogy, utilization of sites in Fn, and disulfide stabilization, 
the matrix induced by aI& closely resembles that assem- 
bled by a&. 
Fn Binding to Cells Expressing an Activated lntegrin 
Is Not Sufficient for Fn Matrix Assembly 
The experiments described above demonstrated that acti- 
vation, normally regulated by integrin cytoplasmic do- 
of ‘251-labeled human plasma Fn. In lanes a-d, samples were prepared 
in nonreducing SDS-PAGE sample buffer (2% SDS, 62.5 mM Tris 
[pH 6.81). In lanes e-h, samples were prepared in the same buffer 
containing 100 mM dithiothreitol. 
mains, controls integrin-mediated Fn matrixassembly. We 
next sought to evaluate the roles of the cytoplasmic do- 
mains apart from their capacity to regulate affinity. To do 
this, we used either anti-LIBSG (07oole et al., 1991) or 
hinge mutants (O’Toole et al., 1994) whose high affinity 
state is independent of distal sequences in the a and B 
cytoplasmic domains. Cells expressing allbA996(33 (see 
Figure l), in which the allb cytoplasmic domain is nearly 
completely truncated, formed Fn fibrils in the presence of 
anti-LIBSG (Figure 6B). This result suggests that the distal 
a cytoplasmic domain is not required for matrix assembly 
once an integrin is activated. Strikingly different results 
were obtained with cells expressing p cytoplasmic domain 
truncation mutants depicted in Figure 1. The B cytoplasmic 
domain truncation mutant ail&A728 (Kd = 72 nM) bound 
Fn with similar affinity to aII& (Kd = 76 nM) when activated 
by anti-LIBSG in suspension (Figure 6F). However, adher- 
ent CHO cells expressing this integrin did not assemble an 
Fn matrix (Figure 6D). CHO cells expressing the activated 
(O’Toole et al., 1994) variant *anba&f13A724, in which the 
I3 cytoplasmic domain was truncated and the VGFFK se- 
quence was deleted from the a cytoplasmic domain, were 
also incapable of assembling an Fn matrix (Figure 6E). 
Thus, some function(s) of the p cytoplasmic domain, in 
addition to inside-out signaling, is required to support Fn 
matrix assembly. 
One important function of the p cytoplasmic domain is 
interaction with the actin cytoskeleton (Solowska et al., 
1989; Hayashi et al., 1990). Consequently, [3 cytoplasmic 
domain truncation could block assembly by preventing the 
interaction of the ligand-occupied integrin with the cy- 
toskeleton. To investigate this further, we added cytocha- 
lasin D to disrupt the actin cytoskeleton of cells expressing 
activated a&. Fn matrix assembly mediated by anti- 
LIBSG-activated allbps was abolished by cytochalasin D 
(Figures 7A and 7B), whereas Fn binding to suspended 
cells was completely unaffected (Table 1). Removal of cy- 
tochalasin D from the cells restored their ability to assem- 
ble an Fn matrix (data not shown). Thus, Fn binding to an 
activated integrin is necessary but not sufficient for an 
integrin to support Fn matrix assembly. 
Discussion 
Our results provide several insights into the mechanism 
of formation of Fn fibrils. First, multiple Fn-binding inte- 
grins can support Fn matrix assembly. Second, integrin 
activation state regulates fibrillogenesis. Third, Fn binding 
to cells expressing an activated integrin is necessary but 
not sufficient for matrix assembly. Additional postoccu- 
panty events involving the p, but not the a subunit cyto- 
plasmic domain are required. Fourth, these postoccu- 
panty events require an intact actin cytoskeleton. Based 
on these data, we propose a model for integrin involve- 
ment in Fn fibrillogenesis, an event of importance in devel- 
opment, wound healing, and malignant transformation. 
This model reconciles previous paradoxical results and 
suggests novel approaches to the therapeutic control of 
Fn matrix assembly. 
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Figure 6. The p3 Cytoplasmic Domain, but Not the alIb Cytoplasmic 
Domain, Is Required for Fn Matrix Assembly by Activated alI& 
CHO Kl cells expressing aIIbA99663 (A and B) or all&A726 (C and 
D) were cultured for 2 days in medium containing 460 nM bovine 
plasma Fn. PBl anti-a& antibody was added to inhibit endogenous 
a&,. Cells were cultured without (A and C) or with anti-LIBSG antibody 
(5.3 PM) (B and D). CHO 82 cells expressing *allbaLAP3A724 (E) were 
cultured for 2 days in medium containing 600 nM bovine plasma Fn 
alone. Fn was visualized by immunofluorescence as described in the 
Experimental Procedures. The scale bar in (A) is 50 pm and applies 
to all panels. Note that truncation of the p3 cytoplasmic domain 
(~,,&A726 [D]) prevents matrix assembly. Similarly, the activating 
Figure 7. Cytochalasin D Blocks Matrix Assembly Mediated by Acti- 
vated aI& 
CHO 82 cells expressing wild-type a& integrin were cultured in me- 
dium containing human plasma Fn (600 nM) and the activating anti- 
body anti-LIBSG (5.3 PM) with (A) or without (B) cytochalasin D (4 PM) 
for 2 days, and Fn was visualized by immunofluorescent staining. The 
scale bar in (A) is 50 urn and applies to both panels. 
The high affinity form of several Fn-binding integrins 
can initiate Fn matrix assembly. In cells in which a& was 
either blocked or absent, aI& could support assembly of 
Fn fibrils. Activation induced by two mechanistically dis- 
tinct cytoplasmic domain mutations or by an activating 
monoclonal antibody was a prerequisite for a& to sup- 
port fibrillogenesis. The matrices formed under control of 
al&and a& were indistinguishable basedon morpholog- 
ical appearance, Fn domains required, or appearance of 
disulfide bond-stabilized multimers. Matrix assembly is a 
precisely regulated process in vivo (Critchley et al., 1979); 
this regulation cannot solely be explained by changes in 
integrin expression repertoires (J. Ramos and D. DeSi- 
mone, personal communication). Because changing inte- 
grin activation regulates matrix assembly, inside-out inte- 
grin signaling (Ginsberg et al., 1992) could modulate the 
assembly process. 
Our finding that Fn-binding integrins other than a$ en- 
able assembly of an Fn matrix suggests that such inte- 
grins, e.g., a& (Char0 et al., 1990) could account for 
matrix assembly in a5 null mice. Indeed, we have observed 
that activated a& supports matrix assembly (C. W., un- 
published data). Both a& and alI& recognizesimilarsites 
in the adjacent ninth and tenth type Ill modules of Fn (Bow- 
ditch et al., 1994; Aota et al., 1994), while a& recognizes 
only the tenth module (Bowditch et al., 1994). Conse- 
*allbuLA chimera expressed with another p3 truncation (allauLA~3A724) 
fails to assemble an Fn matrix (E). 
(F) Binding of Fn to CHO Kl cells expressing ~,,&,A726 (closed 
squares) or wild-type a,& (closed circles) in the presence of the PBl 
monoclonal anti-a&, antibody and anti-LIBS6 antibody (2 BM). The 
binding of ‘251-labeled Fn to the cells was measured as described in 
the Experimental Procedures. The concentration of receptors (33 f 
5 nM for a,,&, 24 f 5 nM for ai&A726. F = 1.06, P = 0.31) and 
their affinity for Fn (K, for a& = 1.32 + 0.25 x lO’/M, Kd = 76 nM; 
K, for ail&A726 = 1.4 f 0.35 x lO’/M, K, = 72 nM [F = 0.01, 
P = I]) were not significantly different. Depicted are pooled data from 
three independent experiments. Each point is the mean of triplicate 
determinations. 
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Table 1. Cytochalasin D Fails to Block Fn Binding to Suspended Cells 
Fn Bound (Molecules/Cell) 
Transfected lntegrin No Cytochalasin D Plus Cytochalasin D 
a,,& plus anti-LIB?% 37,000 k 2,623 35,000 f 1,629 
‘allbaLAB3 16,000 2 1,651 16,000 r?: 2,151 
CHO 82 cells (5 x iO=?ml) expressing the indicated recombinant integrin were incubated at 37°C for 30 min in the presence of 100 nM ‘251-labeled 
Fn. Anti-LIBSG (2 KM) was added to the alI& -expressing cells to stimulate Fn binding. After incubation in the presence or absence of 10 PM 
cytochalasin D, specifically bound Fn was determined as described in the Experimental Procedures. 
a Mean i: SEM of triplicate determinations. 
quently, an integrin capable of binding to the site in the 
ninth module is not absolutely required for assembly. In 
addition, a& integrin mediates Fn matrix assembly, albeit 
indirectly via binding of entactin, which apparently in turn 
binds Fn (Wu et al., 1995). The identification of alternative 
integrins mediating Fn matrix assembly does not a priori 
exclude a& from a unique role in fibrillogenesis. a& is 
critical for normal development, although it is not clear 
whether its principal role is in Fn assembly, in recognition, 
or in providing unique intracellular signals (Yang et al., 
1993). In adult tissues, a& is not generally expressed in 
vivo, except at sitesof tissue injury and repair, concomitant 
with the appearance and recognition of Fn matrices. This 
suggests that a& may be indispensable for certain as- 
pects of matrix assembly and indicates that additional in 
vivo experiments are required to define its special role. 
Fn binding to cells expressing an activated integrin is 
not sufficient to support matrix assembly. Cytochalasin D 
or truncation of the p cytoplasmic domain disrupted Fn 
matrix formation, even though Fn bound to aI,& with a 
similar affinity. This finding establishes that events subse- 
quent to ligand binding are essential for fibril formation. 
The I3 cytoplasmic domain is required for integrin-cyto- 
skeleton associations (Solowska et al., 1989), and cyto- 
chalasin D disrupts the actin cytoskeleton leading to a 
change in cell shape. Furthermore, Fn fibrils codistribute 
with actin-containing stress fibers (Hynes and Destree, 
1978; Roman et al., 1989). Consequently, it is likely that 
the postoccupancy events required for matrix assembly 
depend on the cytoskeleton. Lysophosphatidic acid rap- 
idly stimulates cytoskeletal organization (Ridley and Hall, 
1992) and the binding of the 70K fragment of Fn to cell 
layers (Zhang et al., 1994). In contrast, anti-integrin anti- 
bodies require - 15 min to inhibit 70K binding (Fogerty et 
al., 1990). Our results suggest that this 15 min delay is 
ascribable to the capacity of previously bound Fn to con- 
tinue to support the cytoskeleton-dependent postoccu- 
pancyevents. Thus, integrin participation in matrix assem- 
bly requires an activated Fn-binding integrin, the presence 
of a S cytoplasmic domain, and an intact cellular cyto- 
skeleton. 
The results presented here suggest a working model 
for the role of integrins in the generation of binding sites 
for the N-terminal 70K domain of Fn and subsequent fibril- 
logenesis (Figure 8). One essential step is the binding of 
Fn to an activated integrin, an event that is cell type spe- 
cific and subject to rapid and dynamic regulation (07oole 
et al., 1994; Faull et al., 1994). An additional step involves 
the I3 subunit cytoplasmic domain and the actin cytoskele- 
ton. The first type Ill module of Fn (Ill-l) can bind to the 
70K fragment (Hocking et al., 1994; Aguirre et al., 1994); 
binding is enhanced by denaturation of the fragment 
(Hocking et al., 1994). Moreover, peptides from Ill-1 can 
either inhibit (Morla and Ruoslahti, 1992) or promote (Morla 
et al., 1994) Fn fibrillogenesis. Thus, a change in Ill-1 in- 
volving denaturation or partial unfolding of integrin-bound 
Fn could account for generation of 70K binding sites. Er- 
ickson (1994) has proposed that forces on the order of 
Figure 6. The Integrin-Dependent Steps in Fn Matrix Assembly 
Initially, fibril formation requires activation of the integrin and high 
affinity Fn binding. Subsequently, postoccupancyevents involving the 
cytoskeleton and an intact p cytoplasmic domain expose an active 
assembly site that binds to the N-terminal region (N-terminal matrix 
assembly domain as indicated by the open circles). As discussed in 
the text, Fn type III modules are a candidate for the active assembly 
site. The type Ill site could be activated via mechanochemical transduc- 
tion caused by reversible unfolding of the module in response to force 
generated in the cytoskeleton and transmitted through the integrin. 
Note that the model implies that the Fn molecule must be tethered to 
a second point as well as to the integrin. Because Fn is a dimer linked 
together at its C-terminus and the integrin binds to 111-10, the second 
site of tethering could dictate which type Ill modules were placed under 
tension. For example if the second tethering sitewere at the N-terminus 
of the same subunit via interactions with collagen or another Fn mole- 
cule, then Ill-l to Ill-9 would be stretched. If as, depicted, if the second 
tether was another integrin, then Ill-11 to Ill-15 would be stretched. 
Because unfolding would expose the hydrophobic core of the type III 
module, the most conserved region (Leahy et al., 1992; Main et al., 
1992), it is possible that multiple unfolded repeats could function as 
active assembly sites. Present evidence suggests that this function 
is primarily performed by Ill-1 (Hocking et al., 1994; Aguirre et al., 
1994; Morla and Ruoslahti, 1992; Chernousov et al., 1991). 
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5 pN, which are readily achievable in vivo, are sufficient 
to reversibly unfold type Ill modules. The maintenance of 
cells under tension is required for Fn fibrillogenesis (Halli- 
day and Tomasek, 1995), and the 70K fragment binds 
preferentially to focal adhesions (Dzamba et al., 1994), 
sites of traction between the cell and substratum. The abil- 
ity of integrins to transmit force to the extracellular matrix 
requires the presence of a 6 cytoplasmic domain (Ylanne 
et al., 1993). Thus, the postoccupancy event required for 
exposure of the 70K binding site may involve force applied 
to Fnviathe connection of the integrin to the actin cytoskel- 
eton. Consequently, formation of stable connections be- 
tween the matrix and the cytoskeleton, the property that 
engendered the term integrin (Tamkun et al., 1986), may 
be required for these receptors to support Fn fibrillo- 
genesis. 
In the time since this paper was submitted, Wennerberg 
et al. (1995) have provided additional evidence that (j3 inte- 
grins can assemble an Fn matrix. These authors report 
that 6,-deficient embryonic stem cells assembled an Fn 
matrix. Both av and p3 subunits colocalize with the Fn 
fibrils, suggesting that integrin a& is involved in assem- 
bling the matrix. 
Experimental Procedures 
Antibodies and Reagents 
The inhibitory anti-hamster c5 antibody PBl (Brown and Juliano, 1985, 
1988) the activation-dependent anti-a,,& antibody PACl (Shattil et 
al.,1985),andtheinhibitoryanti-a,,~~santibody2G12(Plowetal., 1985; 
Woods etal., 1984)were obtained from Drs. R. L. Juliano (University of 
North Carolina-Chapel Hill, Chapel Hill, NC), S. Shattil (University 
of Pennsylvania, Philadelphia, PA), and V. L. Woods, Jr. (University 
of California-San Diego, La Jolla, CA), respectively. The activating 
anti-a,,& antibody LIBSG, noninhibitory anti-a& antibodies D57 and 
Ab15 (07oole et al., 1994) and the anti-Fn antibody N294 recognizing 
the RGD-containing cell-binding domain (McDonald et al., 1987) have 
been described previously. Purified mouse IgG and cytochalasin D 
were purchased from Sigma Chemical Company (St. Louis, MO). Bo- 
vine and human plasma Fns, and the 70 kDa N-terminal fragment and 
60 kDa gelatin-binding fragment of human plasma Fn, were prepared 
as previously described (Quade and McDonald, 1988). Fn labeled with 
‘? was prepared using IODO-BEADS (Pierce, Rockford, IL) (Quade 
and McDonald, 1988). The all&-specific peptidomimetic inhibitor 
R044-9883 (Alig et al., 1992) was provided by Dr. B. Steiner (Hoff- 
mann-La Roche, Basel, Switzerland). 
cDNA Vectors, Transfection, and Cell Culture 
CHO Ki cells were obtained from the American Type Culture Collec- 
tion (Rockville, MD). The a&-deficient CHO 82 cell line (Schreiner et 
al., 1989) was provided by Dr. R. L. Juliano. CHO cellswere maintained 
in a-MEM medium (GIBCO Laboratories, Grand Island, NY)containing 
10% fetal bovine serum (FBS) (Atlanta Biologicals, Norcross, GA), 1% 
antibiotic-antimycotic mixture (SigmaChemical Company), and 2 mM 
glutamine. The generation of expression vectors in pCDM8 encoding 
the integrin subunits arIb, allbA996, (xv, all&A, a,,& 83. 8&,, 8,A724, 
and 8,A728 has been described (Loftus et al., 1990; 07oole et al., 
1989,1990,1994)(Figure 1). AllcDNAconstructswereverified by DNA 
sequencing and purified by CsCl centrifugation before transfection into 
the specified CHO cell line (Kl or 82) using lipofectamine reagent 
(Bethesda Research Laboratories, Gaithersburg, MD) as described in 
the protocols of the manufacturer, The cDNA constructs are depicted 
in Figure 1. Constructs encoding activated, e.g., high affinity ligand- 
binding integrins as reported (OToole et al., 1994) are indicated by 
an asterisk in Figure 1 and thereafter. 
Flow Cytometry and Cell Sorting 
Cell surface expression of wild-type alI& integrin and the a& mutants 
was analyzed using the anti-a,,& antibody D57 and an FITC- 
conjugated goat anti-mouse (Tago, Burlingame, CA) secondary anti- 
body on a FACScan (Becton Dickinson lmmunocytometry Systems, 
Rutherford, NJ) as described (Loftus et al., 1990; 07oole et al., 1989, 
1990,1994). Cell lines that stably expressvarious a& mutants (Figure 
1) were isolated by single cell sorting on a FACStar plus (Becton Dickin- 
son lmmunocytometry Systems) as described (Loftus et al., 1990). 
Fn Matrix Assembly Assays 
QualitativeFn matrixassemblywas determined byimmunofluorescent 
staining of cell monolayers, using measures to minimize observer bias 
(McDonald et al., 1987). Cells were suspended in a-MEM medium 
containing 10% FBS depleted of Fn by gelatin affinity absorption and 
supplemented with purified bovine plasma Fn, antibodies, or other 
additives as specified. All reagents were dialyzed against three 
changes of 100 vol of a-MEM medium and filtered through a 0.2 pm 
filter before adding to culture medium. Cells were plated in Lab-Tek 
8-chamber culture slides (Nunc, Incorporated, Naperville, IL; 200 PI/ 
well) or 12-well HTC slides (Cel-Line, Incorporated, Newfield, NJ; 50 
nl/well) at a final density of 2.5 x 1 O5 cells/ml and cultured in a 37OC 
incubator under a 5% CO,, 95% air atmosphere. Cells were fixed with 
3.7% paraformaldehyde and stained with a rabbit anti-bovine plasma 
Fn antibody (32 wglml) and Cy3-conjugated goat anti-rabbit IgG anti- 
bodies (Jackson ImmunoResearch Laboratories. Incoroorated. West 
Grove, PA; 7.5 rig/ml). Stained cell monolayers were observed using 
a Nikon FXA epifluorescence microscope. and reoresentative fields 
were photographed using KodakT-Max 40dor Ektachrome 16OOdirect 
positive slide film. To obtain representative images, exposure times 
for different experimental conditions were fixed, using the positive, 
i.e., matrix-forming cells, as the index exposure length. All critical im- 
munostaining experiments were reviewed and coded independently 
by one observer (J. A. M.) without knowledge of the experimental 
conditions. 
Isolation and Biochemical Characterization of 
Extracellular Matrix Fn 
Cells were cultured in 35 mm tissue culture elates (Cornina. Incoroo- 
rated, Corning, NY) in a-MEM medium containing‘lO% Fn:depleted 
FBS, 123 nM ‘251-labeled human plasma Fn (1.46 x 1 05comlnmoh. and 
\ -  ~, I I  
other additives as specified. After seeding (2 days), the cell monolayers 
were washed twice with PBS and harvested with a cell scraper. The 
extracellular matrix fraction was isolated bv seauential extraction of 
I  
the cells with the following: first, 3% Triton X-100 in PBS containing 
10 nM EDTA, 0.2 mM 4-[2-aminoethylj-benzenesulfonvl fluoride. 10 
nM leupeptin, and 1 pM pepstatin; second, 100 rig/ml DNase I in 50 
mM Tris (pH 7.4) IO mM MnCI*, 1 M NaCI; third, 2% deoxycholate in 
Tris (pH 8.8) 10 mM EDTA, 0.2 mM 4-[2-aminoethylj-benzenesulfonyl 
fluoride, 10 nM leupeptin, and 1 pM pepstatin (Wu et al., 1993). ‘?m 
labeled Fn in the deoxycholate-insoluble extracellular matrix fraction 
was analyzed by reducing and nonreducing SDS-PAGE (5% stacking 
and 7.5% running polyacrylamide gel) and autoradiography. 
Fn Binding to Cells 
The binding of ‘251rlabeled Fn to CHO cells was quantified as described 
(OToole et al., 1990; Plow and Ginsberg. 1981). and the ‘251-labeled 
I .  I .  
Fn binding results were analyzed using the LIGAND program (Munson 
and Rodbard, 1980). In brief, cells were harvested with EDTA and 
trypsin and resuspended in a modified Tyrode’s buffer (150 mM NaCI, 
2.5 mM KCI, 2 mM NaHC03, 2 mM MgClz, 2 mM CaC12, 1 mglml BSA, 
and 1 mglml dextrose). Cells(0.2 ml of5 x 106cells/ml)were incubated 
with ‘Z51-labeled Fn for 30 min at 37OC. Aliquots (50 ~1) were layered 
on 0.3 ml of 20% sucrose and centrifuged for 3 min at 12,000 rpm. 
‘251-labeled Fn associated with the cell pellet was determined by scintil- 
lation spectrometry. 
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